Cargando…

Interleukin-35 expression is associated with colon cancer progression

Colon cancer development is closely related to inflammation. Thus, we conducted the present investigation to study the effects of IL-35 (Interleukin 35), a newly identified anti-inflammatory factor, on colon cancer development. We first evaluated the IL-35 expression in 186 pairs of colon cancer sam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jian, Mao, Tao, Wang, Shuyun, Wang, Dongsheng, Niu, Zhaojian, Sun, Zhenqing, Zhang, Jianli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641072/ https://www.ncbi.nlm.nih.gov/pubmed/29069729 http://dx.doi.org/10.18632/oncotarget.17751

Ejemplares similares

Interleukin-35 is associated with the tumorigenesis and progression of prostate cancer
por: Zhu, Jialin, et al.
Publicado: (2019)

Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity
por: Jiang, QiangYue, et al.
Publicado: (2017)

Interleukin 35 regulates interleukin 17 expression and T helper 17 in patients with proliferative diabetic retinopathy
por: Yan, Ai, et al.
Publicado: (2022)

IL-35 expression in hepatocellular carcinoma cells is associated with tumor progression
por: Long, Jun, et al.
Publicado: (2016)

Correction: Colon cancer-induced interleukin-35 inhibits betacatenin- mediated pro-oncogenic activity
por: Jiang, Yueqiang, et al.
Publicado: (2018)

Interleukin 35: protective role and mechanism in type 1 diabetes
por: Zhang, Si-Ming, et al.
Publicado: (2023)

Interleukin-18 Is a Prognostic Marker and Plays a Tumor Suppressive Role in Colon Cancer
por: Feng, Xiaodong, et al.
Publicado: (2020)

Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
por: Zhu, Jialin, et al.
Publicado: (2020)

Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity
por: Jiang, Yueqiang, et al.
Publicado: (2022)

Interleukin 35 is an independent prognostic factor and a therapeutic target for nasopharyngeal carcinoma
por: Zhang, Yongquan, et al.
Publicado: (2015)

Interleukin-22 promotes aerobic glycolysis associated with tumor progression via targeting hexokinase-2 in human colon cancer cells
por: Liu, Yulin, et al.
Publicado: (2017)

Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma
por: Ye, Bo-Gen, et al.
Publicado: (2016)

High Expression of lncRNA AFAP1-AS1 Promotes the Progression of Colon Cancer and Predicts Poor Prognosis
por: Bo, Hao, et al.
Publicado: (2018)

Different expression levels of interleukin-35 in asthma phenotypes
por: Li, Wei, et al.
Publicado: (2020)

Interleukin-35 Level Is Reduced in Patients with Chronic Hepatitis B Virus Infection
por: Cheng, Sheng-Tao, et al.
Publicado: (2018)

Macrophage-secreted interleukin-35 regulates cancer cell plasticity to facilitate metastatic colonization
por: Lee, Chih-Chan, et al.
Publicado: (2018)

Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Fu, Yi-Peng, et al.
Publicado: (2016)

Interleukin-35 in autoimmune dermatoses: Current concepts
por: Xie, Yuming, et al.
Publicado: (2022)

Interleukin-12p35 deficiency enhances mitochondrial dysfunction and aggravates cardiac remodeling in aging mice
por: Ye, Jing, et al.
Publicado: (2020)

Elevated level of Interleukin-35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1/STAT3
por: Ma, Yanhui, et al.
Publicado: (2016)

Interleukin-37 mediates the antitumor activity in colon cancer through β-catenin suppression
por: Yan, Xiaofei, et al.
Publicado: (2017)

Reduced circulating interleukin 35 is associated with enhanced peripheral T cell function in primary biliary cholangitis
por: Liu, Siqi, et al.
Publicado: (2023)

Clinical significance and comparison of flotillin 1 expression in left and right colon cancer
por: Baig, Nadia, et al.
Publicado: (2019)

Interleukin-11 Promotes the Progress of Gastric Carcinoma via Abnormally Expressed Versican
por: Zhang, Zhenwei, et al.
Publicado: (2012)

Serum interleukin-35 and pentraxin-3 levels in patients with mild acute pancreatitis
por: Aksoy, Evrim Kahramanoğlu, et al.
Publicado: (2019)

Interleukin-27 and interleukin-35 in de novo acute myeloid leukemia: expression and significance as biological markers
por: Ahmed, Heba A, et al.
Publicado: (2019)

Interleukin 33-mediated inhibition of A-type K(+) channels induces sensory neuronal hyperexcitability and nociceptive behaviors in mice
por: Wang, Yiru, et al.
Publicado: (2022)

Interleukin-35 on B cell and T cell induction and regulation
por: Huang, Ai, et al.
Publicado: (2017)

The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis
por: Omenesa Bello, Ramatu, et al.
Publicado: (2018)

Elevated levels of interleukin‐35 and interleukin‐37 in adult patients with obstructive sleep apnea
por: Chen, Bi, et al.
Publicado: (2021)

Interleukin-35 as an Emerging Player in Tumor Microenvironment
por: Xue, Wenhua, et al.
Publicado: (2019)

Immunomodulatory cytokine interleukin-35 and immune thrombocytopaenia
por: Zhu, Jing-Jing, et al.
Publicado: (2020)

Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis
por: Xin, Pan Lin, et al.
Publicado: (2021)

miRNA-Based Signature Associated With Tumor Mutational Burden in Colon Adenocarcinoma
por: Xue, Weijie, et al.
Publicado: (2021)

Prevention of Autoimmune Diabetes by Ectopic Pancreatic β-Cell Expression of Interleukin-35
por: Bettini, Maria, et al.
Publicado: (2012)

Tertiary lymphoid organs are associated with the progression of kidney damage and regulated by interleukin-17A
por: Luo, Ran, et al.
Publicado: (2021)

A Prognostic Model of Angiogenesis and Neutrophil Extracellular Traps Related Genes Manipulating Tumor Microenvironment in Colon Cancer
por: Zhang, Dongsheng, et al.
Publicado: (2023)

Interleukin-35 Attenuates D-Galactosamine/Lipopolysaccharide-Induced Liver Injury via Enhancing Interleukin-10 Production in Kupffer Cells
por: Zheng, Xing-Feng, et al.
Publicado: (2018)

Inducible nitric oxide synthase-expressing myeloid-derived suppressor cells regulated by interleukin 35 contribute to the pathogenesis of psoriasis
por: Zhang, Junfeng, et al.
Publicado: (2023)

Overexpression of interleukin‐35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection
por: Zhang, Mei‐xia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rud08po7lj04v3l2kitkri5o08